Proc (Bayl Univ Med Cent)
November 2020
An 81-year-old woman with known schizophrenia presented to the psychiatric consult service with an acute exacerbation of tactile and visual hallucinations and paranoid delusions. This case report examines an atypical progression of illness, including the patient's unusually high functional status and maintenance of activities of daily living well into her disease course despite persistent positive symptoms, highlighting potential benefits of early pharmacological treatment and lifestyle choices.
View Article and Find Full Text PDFNeurological manifestations of coronavirus disease 2019 most commonly present in severe cases and range from mild complications, such as headache and dizziness, to severe complications, such as encephalopathy and acute cerebrovascular disease. Seizures, however, are an underreported neurological manifestation of this disease. We present three critically ill coronavirus disease 2019 patients with EEG monitoring who developed new-onset seizures and encephalopathy up to three-and-a-half weeks after symptom onset.
View Article and Find Full Text PDFBackground: Cytokine release storm (CRS) is a potentially fatal, hyperinflammatory condition common to both coronavirus disease 2019 (COVID-19) and reactive hemophagocytic lymphohistiocytosis (rHLH). We present our experience with the use of a diagnostic score, developed for rHLH, in a kidney transplant recipient hospitalized with COVID-19.
Methods: We applied the H-Score to risk-stratify our patient to help predict his hospital course.
Proc (Bayl Univ Med Cent)
July 2020
A 24-year-old man with a past medical history of behavioral disturbances and spastic tetraplegia secondary to traumatic brain injury presented to the psychiatry consult service with acute exacerbation of agitation and aggression. The patient's behavioral disturbances were previously reduced with 1500 mg daily of valproic acid (VPA). Prior to admission, VPA was discontinued due to elevated serum ammonia levels of 96 μmol/L and clinical findings consistent with valproate-induced hyperammonemic encephalopathy (VIHE), such as lethargy, confusion, frank delirium, and ataxia.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
September 2020